Showing results (521-530 of 705) with videos related to

Sort By:
Pageof 71
Analytical and Bioanalytical Chemistry|January 13, 2015
Combining capillary electrophoresis and next-generation sequencing for aptamer selectionKathryn R Riley, Jason Gagliano, Jiajie Xiao, et al.
Plos Neglected Tropical Diseases|August 31, 2018
"Zika is everywhere": A qualitative exploration of knowledge, attitudes and practices towards Zika virus among women of reproductive age in Iquitos, PeruCaroline T Weldon, Amy R Riley-Powell, Ines M Aguerre, et al.
Diabetes, Obesity & Metabolism|October 8, 2025
Relative efficacy of GLP-1 and GLP-1/GIP receptor agonists in the prevention of alcohol-use disorders using a target trial emulation approachAlex E Henney, David R Riley, Megan Heague, et al.
Arthritis Care & Research|November 1, 2023
Changes in Characteristics of Patients Initiating and Discontinuing Advanced Therapies for Rheumatoid Arthritis Following the Release of Safety DataStephanie Song, Bryant R England, Brian Sauer, et al.
Nature|May 21, 2015
Cardiac lymphatics are heterogeneous in origin and respond to injuryLinda Klotz, Sophie Norman, Joaquim Miguel Vieira, et al.
Urology|February 11, 1998
Safety and efficacy of the Alexandrite laser for the treatment of renal and ureteral calculiM S Pearle, S M Sech, C G Cobb, et al.
BMC Bioinformatics|September 1, 2011
CloVR: a virtual machine for automated and portable sequence analysis from the desktop using cloud computingSamuel V Angiuoli, Malcolm Matalka, Aaron Gussman, et al.
RMD Open|January 27, 2026
Characteristics, treatments and outcomes of patients with dermatomyositis using real-world dataMichael George, Ellen Romich, Thomas R Riley, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Multiplexed Targeted Spatial Mass Spectrometry Imaging Assays to monitor lipids and NAD + metabolites in CD38 knockout mice exhibiting improved metabolismCharles A Schurman, Joanna Bons, Prasanna Vadhana Ashok Kumaar, et al.
Clinical Therapeutics|July 27, 2024
SGLT2 Inhibitors, but Not GLP-1 Receptor Agonists, Reduce Incidence of Gout in People Living With Type 2 Diabetes Across the Therapeutic SpectrumFrank G Preston, Matthew Anson, David R Riley, et al.
Pageof 71